Filing Details

Accession Number:
0001408408-17-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-21 17:37:31
Reporting Period:
2017-07-19
Filing Date:
2017-07-21
Accepted Time:
2017-07-21 17:37:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130166 Cyclacel Pharmaceuticals Inc. CYCC Pharmaceutical Preparations (2834) 911766850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331271 Bryan Kenneth Dart P. O. Box 31300
Grand Cayman E9 KY1-1206
No No Yes No
1408408 Ltd Capital Eastern 10 Market Street, #773
Camana Bay
Grand Cayman E9 KY1-9006
No No Yes No
1488856 Ltd. Services Portfolio 10 Market Street, # 773
Camana Bay
Grand Cayman E9 KY1-9006
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-19 850,000 $2.00 2,167,261 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2017-07-19 1 $0.00 850,000 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1 No 4 P Direct
Footnotes
  1. On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.